--- title: 'Sox Compliance Manager at BridgeBio Pharma' canonical: 'https://feeny.ai/job/sox-compliance-manager-bridgebio-pharma-san-francisco-f2genkpypxfv' type: 'job' last_seen: '2026-10-28' --- # Sox Compliance Manager at BridgeBio Pharma - **Company:** BridgeBio Pharma - **Location:** San Francisco, CA - **Compensation:** $135k–$170k - **Posted:** 2026-10-26 - **Last confirmed live:** 2026-10-28 - **Apply:** https://job-boards.greenhouse.io/bridgebio/jobs/5275277007 ## Job description Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible. Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work. The SOX Manager will report to and work under the guidance of the Senior Director, SOX Compliance, supporting day-to-day activities within BridgeBio’s Sarbanes-Oxley (SOX) compliance program. This hands-on role will independently execute assigned workstreams, exercise sound judgment, and seek guidance or escalate significant matters as appropriate. The role partners with Accounting, IT, and business process owners to evaluate internal control over financial reporting (ICFR). The ideal candidate brings both Big 4 public accounting and public-company industry experience, preferably life sciences. ## Responsibilities - Assist the Senior Director, SOX Compliance, with the annual SOX program, including risk assessment, scoping, walkthroughs, testing, and reporting; independently manage assigned activities while seeking guidance on complex or significant matters. - Develop and maintain an understanding of the company’s business operations, financial processes, systems, policies, and procedures, seeking guidance where additional context or clarification is needed. - Identify any gaps and recommend practical improvements to processes. - Coordinate assigned testing with the co-sourced internal audit team and external auditors; review test plans and workpapers for alignment with the documented process, identified risks, and control objectives, escalating significant questions or issues as appropriate. - Assess assigned control exceptions and investigate root causes; support deficiency severity evaluations under the Senior Director’s guidance, including consideration of compensating controls and potential financial reporting impact. - Partner with control owners to develop remediation plans and independently monitor assigned actions and coordinate validation of remediation effectiveness, seeking guidance on delays, disputes, or significant issues. - Assist in performing initial assessment of the SOX implications of new systems, process changes, and business developments. - Coordinate with IT SOX on automated controls, interfaces, and dependencies on IT general controls, and consult with the Senior Director on significant conclusions. - Assist in preparing status updates, deficiency summaries, and supporting materials for the Senior Director’s review and communications with senior management and the Audit Committee, incorporating guidance and feedback as appropriate. ## Qualifications - Bachelor’s degree in accounting. - Strong knowledge of SOX Section 404, the COSO internal control framework, financial processes, and US GAAP; ability to apply this knowledge to control design, testing, and deficiency evaluation. - 5–7 years of combined Big 4 public accounting and public-company industry experience, life science industry experience preferred. - Strong organizational and analytical skills, attention to detail, and the ability to manage multiple priorities independently in a fast-paced environment while recognizing when to seek guidance or escalate issues. - Experience with SOX management platforms such as Workiva and enterprise systems such as SAP, Coupa, or Workday is preferred. At BridgeBio, we strive to provide a market-competitive total rewards package, including base pay, an annual performance bonus, company equity, and generous health benefits. Below is the anticipated salary range for candidates for this role who will work in California. The final salary offered to a successful candidate will depend on several factors that may include but are not limited to the type and length of experience within the job, type, and length of experience within the industry, educational background, location of residence and performance during the interview process. BridgeBio is a multi-state employer, and this salary range may not reflect positions based in other states. Salary $135,000—$170,000 USD As a global company, our comprehensive benefits may vary based on location.  We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return. For BridgeBio Full-Time U.S Based Roles: Financial & Rewards - Market-leading compensation - 401(k) with employer match - Employee Stock Purchase Program (ESPP) - Pre-tax commuter benefits (transit and parking) - Referral bonus for hired candidates - Subsidized lunch and parking on in-office days Health & Well-Being - 100% employer-paid medical, dental, and vision premiums for you and your dependents - Health Savings Account (HSA) with annual employer contributions, plus Flexible Spending Accounts (FSA) - Fertility & family-forming benefits - Expanded mental health support (therapy and coaching resources) - Hybrid work model with flexibility - Flexible, “take-what-you-need” paid time off and company-paid holidays - Comprehensive paid medical and parental leave to care for yourself and your family Skill Development & Career Paths: - People are part of our growth and success story - from discovery to active drug trials and FDA pipelines, there are endless opportunities for skill development and internal mobility - We provide career pathing through regular feedback, continuous education and professional development programs via LinkedIn Learning, LifeLabs, & BetterUp Coaching - We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities By applying, you acknowledge that BridgeBio will process your personal information as described in our [Global Candidate Privacy Notice](https://bridgebio.com/bridgebio-global-candidate-privacy-notice). ## About BridgeBio Pharma ## Company Overview - **One-liner**: BridgeBio Pharma develops transformative medicines for genetic conditions, using a decentralized hub-and-spoke model to accelerate drug development from early research to commercialization. - **Entity Type**: Public (Nasdaq: BBIO) - **Headquarters**: Palo Alto, California, USA (with hybrid offices in San Francisco, CA) - **Founded**: Not explicitly stated in provided sources; the company references “over the past 10 years” as of 2026, suggesting founding around 2015–2016. - **Founders**: Not publicly available from provided sources. ## Core Business - **Primary industry**: Biotechnology / Genetic disease therapeutics - **Target customers**: Patients living with genetic conditions, healthcare providers, payers, and academic research partners - **Mission**: “To develop transformative medicines for genetic conditions” and “bridge the gap between advancements in genetic science and meaningful medicines for underserved patient populations.” ## Products & Services BridgeBio’s pipeline includes both approved therapies and investigational candidates across dozens of indications. Key offerings: - **Acoramidis**: Approved for transthyretin amyloidosis (ATTR) – a first-in-class treatment with $8B+ peak year sales potential. - **Infigratinib**: Phase 3 completed for achondroplasia; published in the *New England Journal of Medicine* (2026). - **BBP-418**: Investigational for Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9). - **Encaleret**: Investigational for Autosomal Dominant Hypocalcemia Type 1 (ADH1). - **BBP-812**: Investigational for Canavan Disease. - **BridgeBio Oncology Therapeutics (BBOT)**: Subsidiary focused on RAS and PI3Kα-driven cancers. - **GondolaBio**: Subsidiary developing bioavailable small molecule inhibitors for oncology. - **Other programs**: Covering hypochondroplasia, chronic hypoparathyroidism, and more. The company has received **3 FDA approvals** and has over **70+ peer-reviewed publications**. ## Market Standing - **Valuation / Market Cap**: Not explicitly stated in provided data; as a public company, current market cap can be found on financial platforms (e.g., ~$8B based on peak sales potential, but not a direct valuation number). - **Key Metric**: **3 FDA-approved medicines**; **2000+ patients enrolled** in global clinical trials; **6 Phase 3 trials** conducted over the past 10 years. - **Notable Investors / Partners**: Not detailed in provided sources, but the company partners with leading academic institutions to advance early-stage research. - **Growth Signals**: Recent publication of Phase 3 PROPEL 3 trial results in NEJM (June 2026); expansion into oncology via BBOT and GondolaBio; 100% of pipeline is first-in-class or best-in-class; 48 unique disease indications targeted. ## Competitive Advantages - **Hub-and-spoke model**: Decentralized structure where autonomous affiliate teams (spokes) focus on specific conditions, while a central hub provides clinical, regulatory, and commercial expertise. This enables speed, scalability, and risk reduction. - **First-in-class / best-in-class focus**: 100% of pipeline aims to be first or best in class, targeting underserved genetic conditions with clear biological rationale. - **Speed and adaptability**: The model allows rapid pivoting to the most promising opportunities, reducing development timelines compared to traditional biotech. - **Strong scientific foundation**: Over 70 peer-reviewed papers and collaborations with top academic institutions. ## Strategic Focus - **Advance late-stage pipeline**: Prioritize Phase 3 programs (e.g., infigratinib for achondroplasia, acoramidis for ATTR) and seek additional FDA approvals. - **Expand into oncology**: Leverage subsidiaries BBOT and GondolaBio to address RAS/PI3Kα-driven cancers. - **Maintain urgency**: “Every minute counts” – continue to operate with speed and autonomy to bring treatments to patients faster. - **Build on commercial success**: Leverage existing approved products to fund further R&D and expand global reach. ## Why Work Here - **Award-winning culture**: Named **#1 Best Place to Work** by BioSpace (2026, small biotech category) with an **88% employee engagement score** in 2025. - **Flexible work model**: Hybrid policy with offices in San Francisco and Palo Alto, CA; “flexible working model” emphasized. - **Compensation and benefits**: Market-leading pay, comprehensive healthcare, and strong emphasis on growth and internal mobility. - **Impact-driven mission**: Work on transformative treatments for genetic conditions where patient need is urgent – “Impatient for Patients” is a core mantra. - **Values**: Put patients first, let science speak, think independently, speak up, and act with urgency. The culture is described as “high on standards, low on convention.” - **Growth opportunities**: 113 open jobs (as of mid-2026) across functions including clinical, regulatory, manufacturing, commercial, and corporate; talent community available for future roles. ## Sources 1. [bridgebio.com](https://bridgebio.com/) – Home page with pipeline overview and $8B peak sales potential 2. [bridgebio.com/about](https://bridgebio.com/about) – Company description, hub-and-spoke model, and key metrics 3. [bridgebio.com/careers](https://bridgebio.com/careers) – Careers page with awards, culture, and benefits 4. [investor.bridgebio.com](https://investor.bridgebio.com/overview/default.aspx) – Investor relations overview, latest news, and corporate presentation 5. [job-boards.greenhouse.io/bridgebio](http://job-boards.greenhouse.io/bridgebio) – Current job listings (113 roles) and departmental categories ## Other roles at BridgeBio Pharma - [Senior Marketing Manager, Skeletal Dysplasia](https://feeny.ai/job/senior-marketing-manager-skeletal-dysplasia-bridgebio-pharma-san-francisco-sdpr3bac78fx) — San Francisco, CA / Palo Alto, CA - [Senior Field Medical Director, Strategic Operations](https://feeny.ai/job/senior-field-medical-director-strategic-operations-bridgebio-pharma-san-4150ptsdsp16) — San Francisco, CA - [BD&Ops Director / Sr. Director](https://feeny.ai/job/bd-ops-director-sr-director-bridgebio-pharma-palo-alto-ffv4vme42c72) — Palo Alto, CA - [Field Reimbursement Manager, Southwest - Skeletal Dysplasia](https://feeny.ai/job/field-reimbursement-manager-southwest-skeletal-dysplasia-bridgebio-pharma-fay16wzevn61) — United States - [Field Reimbursement Manager, Southeast - Skeletal Dysplasia,](https://feeny.ai/job/field-reimbursement-manager-southeast-skeletal-dysplasia-bridgebio-pharma-fxt0f3sdwdn4) — United States - [Field Reimbursement Manager, Midwest - Skeletal Dysplasia](https://feeny.ai/job/field-reimbursement-manager-midwest-skeletal-dysplasia-bridgebio-pharma-united-b7mx2yyg45rj) — United States - [Director, Field Reimbursement - East](https://feeny.ai/job/director-field-reimbursement-east-bridgebio-pharma-united-states-rbt720p8m8g3) — United States - [Senior Manager / Associate Director, Medical Information](https://feeny.ai/job/senior-manager-associate-director-medical-information-bridgebio-pharma-united-43ankxcabebt) — United States - [Director, Government Pricing & Contract Operations](https://feeny.ai/job/director-government-pricing-contract-operations-bridgebio-pharma-san-francisco-3drkp53atz53) — /san Francisco CA & Palo Alto, CA - [Senior Manager, Corporate Communications](https://feeny.ai/job/senior-manager-corporate-communications-bridgebio-pharma-palo-alto-95nq7sks6gtc) — Palo Alto, CA